Minimally Differentiated Acute Myeloid Leukemia (AML M0): Clinico-Biological Findings of 29 Cases

References

• Lee EJ, Pollack A, Leavitt RD, Testa JR, Schiffer CA. Minimally differentiated acute nonlymphocytic leukemia: a distinct entity. Blood 1987; 70: 1400–1406
   PubMed Web of Science ®Google Scholar
• Musto P, Cascavilla N, Melillo L, Matera R, Carotenuto M. Clinical usefulness of immunocytochemical detection myeloperoxidase in undifferentiated and byphenotypic acute leukemias. Haematologica 1991; 76: 434–436
   PubMedGoogle Scholar
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton D AG, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• Villamor N, Zarco MA, Rozman M, Ribera JM, Feliu E, Montserrat E. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics. Leukemia 1998; 12: 1071–1075
   PubMed Web of Science ®Google Scholar
• Venditti A, Del Poeta G, Stasi R, Masi M, Bruno A, Buccisano F, Cox C, Coppetelli U, Aronica G, Simone MD, Papa G, Tribalto M, Amadori S. Minimally differentiated acute myeloid leukaemia (AML MO): cytochemical, immu-nophenotypic and cytogenetic analysis of 19 cases. Br J Haematol 1994; 88: 784–791
   PubMed Web of Science ®Google Scholar
• Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox C, Stasi R, Bruno A, Aronica G, Maffei L, Suppo G, Simone MD, Forte L, Cordero V, Postorino M, Tufilli V, Isacchi G, Masi M, Papa G, Amadori S. Minimally undifferentiated acute myeloid leukemia (AML MO): comparison of 25 cases with other French-American-British subtypes. Blood 1997; 89: 621–629
   PubMed Web of Science ®Google Scholar
• Venditti A, Del Poeta G, Stasi R, Buccisano F, Aronica G, Bruno A, Cox C, Maffei L, Tamburini A, Papa G, Amadori S. Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML MO) and its clinical implications (letter). Blood 1996; 87: 418
   PubMed Web of Science ®Google Scholar
• Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, van Horshoven A, Criel A, Stul M, Dal Clin P, Hernandez J, Chatelain B, Doyen C, Louwagie A, Castoldi G, Cassiman JJ, Van Den Berghe H. Cytogenetic profile of minimally differentiated (FAB MO) acute myeloid leukemia: correlation with clinicobiologic findings. Blood 1995; 85: 3688–3694
   PubMed Web of Science ®Google Scholar
• Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML MO). Blood 1994; 83: 1619–25
   PubMed Web of Science ®Google Scholar
• Cohen PL, Hoyer JD, Kurtin PJ, Dewald GW, Hanson CA. Acute myeloid leukemia with minimal differentiation. A multiple parameter study. Am J Clin Pathol 1997; 109: 32–38
   Web of Science ®Google Scholar
• Yokose N, Ogata K, Ito K, Mikaye K, An E, Inokuchi K, Yamada T, Gomi S, Tanabe Y, Ohki I, Kuwabara T, Hasegawa S, Shinohara T, Dan K, Nomura T. Chemotherapy for minimally differentiated acute myeloid leukemia (AML MO). A report on five cases and review of the literature. Am J Hematol 1993; 66: 67–70
   Google Scholar
• Cascavilla N, Greco MM, Ladogana S, La Sala A, Melillo L, Musto P, Nobile M, Piano A, Carotenuto M. Acute myeloid leukemia: correlation between FAB classification criteria and surface antigenic markers. Haematologica 1988; 73: 37–42
   PubMed Web of Science ®Google Scholar
• Musto P, Bavaro P, Cascavilla N, Melillo L, Nobile M. Tecniche immunoenzimatiche di caratterizzazione cellulare: particolari possibilità applicative nella citologia onco-ematologica. Medicina 1987; 7: 8–42
   Google Scholar
• Pizzolo G, Vincenzi C, Nadali G, Veneri D, Vinante F, Chilosi M, Basso G, Connelly MC, Janossy G. Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation. Leukemia 1994; 8: 672–676
   PubMed Web of Science ®Google Scholar
• Knapp W, Strobl H, Majdic O. Flow cytometry analysis of cell surface and intracellular antigens in leukemia diagnosis. Cytometry 1994; 18: 187–198
   PubMedGoogle Scholar
• ICSN. Giudelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature, F. Mitelmann. Karger, BaselSwitzerland 1995
   Google Scholar
• Armitage P. Statistical methods in medical research. John Wiley & Sons, New York 1971
   Google Scholar
• Cascavilla N, Musto P, Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M. CD117 (c-kit) is a restrict antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Haematologica 1998; 83: 392–397
   PubMed Web of Science ®Google Scholar
• Cascavilla N, Musto P, Arena G, Ladogana S, Melillo L, Carella AM, Perla G, Matera R, Carotenuto M. Are “early” and “late” T-acute lymphoblastic leukemias different diseases? A single center study of 34 patients. Leuk Lymph 1996; 21: 437–442
   PubMed Web of Science ®Google Scholar
• Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331–1335
   PubMed Web of Science ®Google Scholar
• Schiavone M, Lo Pardo C, DiNoto R, Manzo C, Ferrara F, Vacca C, Del Vecchio L. Expression of the leucocyte common antigen (LCA, CD45) isoforms RA and RO in acute haematological malignancies: possible relevance in the definition of new overlap points between normal and leukaemic haemapoiesis. Br J Haematol 1995; 91: 899–906
   PubMed Web of Science ®Google Scholar
• Caligiuri MA, Strout MP, Gililland DG. Molecular biology of acute myeloid leukemia. Semin Oncol 1997; 24: 32–44
   PubMed Web of Science ®Google Scholar
• Foa R, Casorati G, Giubellino MC, Basso G, Schirò R, Pizzolo G, Lauria F, Lefranc MP, Rabbits TH, Migone N. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia. J Exp Med 1987; 165: 879–890
   PubMed Web of Science ®Google Scholar
• Serementis SV, Pelicci PG, Tabilio A, Ubriaco A, Grignani F, Cuttner J, Winchester RJ, Knowles DM, II, Dalla-Favera R. High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase. J Exp Med 1987; 165: 1703–1712
   PubMed Web of Science ®Google Scholar
• Cuneo A, Ferrant A, Michaux JL, Demuynck H, Boogaerts M, Louwagie A, Doyen C, Stul M, Cassiman JJ, Dal Cin P, Castoldi G, Van den Berghe H. Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica 1996; 81: 423–427
   PubMed Web of Science ®Google Scholar
• Asou N, Suzushima H, Hattori T, Nishikawa K, Wang JX, Okubo T, Oura K, Sato M, Kawano F, Shido T, Takatsuki K. Acute unclassified leukemia originating from undifferentiated cells with the aberrant rearrangement and expression of immunoglobulin and T-cell receptor genes. Leukemia 1991; 5: 293–299
   PubMed Web of Science ®Google Scholar
• Traweek ST, Liu J, Braziel RM, Johnson RM, Brynes RK. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-MO) using in situ hybridization. Diagn Mol Pathol 1995; 4: 212–219
   PubMed Web of Science ®Google Scholar
• Bassan R, Biondi A, Benvestito S, Tini ML, Abbate M, Viero P, Barbui T, Rambaldi A. Acute undifferentiated leukemia with CD7+ and CD 13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features. Cancer 1992; 69: 396–404
   PubMed Web of Science ®Google Scholar
• Del Poeta G, Stasi A, Venditti A., Cox C, Aronica G, Masi M, Bruno A, Simone MD, Buccisano F, Papa G. CD7 expression in acute myeloid leukemia. Leuk Lymph 1995; 17: 111–119
   PubMed Web of Science ®Google Scholar
• Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G, Bruno A, Del Moro B, Epiceno AM, Battaglia A, Forte I, Postorino M, Cordero V, Santinelli S, Amadori S. Prognostic relevance of the expression of TdT and CD7 in 335 cases of acute myeloid leukemia. Leukemia 1998; 12: 1056–1063
   PubMed Web of Science ®Google Scholar
• Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the FAS ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–1178
   PubMed Web of Science ®Google Scholar
• Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy- induced apoptosis in a human leukemia cell line. Blood 1993; 328: 614–619
   Google Scholar